Summary
In order to evaluate the role of the sympathetic nervous system in the development and maintenance of spontaneous hypertension, spontaneously hypertensive and normotensive rats were give 6-hydroxydopamine (6-OH-dopamine).
A single i.v. dose of 6-OH-dopamine (100 mg/kg) caused a biphasic rise in blood pressure in both hypertensive and normotensive rats.
During long-term treatment the first dose of 6-OH-dopamine (25 or 50 mg/kg i.v.) lowered the blood pressure, measured 24 h after injection, two or three times more in hypertensive than in normotensive rats. As a result, the blood pressure reached the same level in both groups, i.e. 90–100 mm Hg. Within three days this hypotension subsided. After repeated weekly administration of 6-OH-dopamine the depressor effect declined gradually and after 4 weeks it was no longer significant. When this stage was reached, adrenal demedullation as such neither lowered the basal blood pressure, nor prevented the development of tolerance to 6-OH-dopamine. Accordingly, the adrenal medulla is not decisive in maintaining the blood pressure and in the development of tolerance to the depressor effect of 6-OH-dopamine in spontaneously hypertensive and normotensive animals.
After treatment with 8 weekly doses of 6-OH-dopamine, the pressor response to noradrenaline increased in both hypertensive and normotensive rats, while the response to tyramine decreased.
When, on the second day after birth, new-born rats of the hypertensive strain were given a single dose of 6-OH-dopamine (50 mg/kg i.p.) the development of hypertension was inhibited to some degree. This inhibition was more marked when the animals were given weekly doses of 6-OH-dopamine (50 mg/kg i.p.) during 5 weeks. On the other hand, when pregnant rats of the same strain received 6-OH-dopamine (50 mg/kg i.v.) twice during the last week before delivery, the offsprings did develop hypertension.
It is evident that the adrenergic nervous system plays an important part in the development of hypertension in rats of a spontaneously hypertensive strain, but it is no longer of essential importance once the hypertension is established.
Similar content being viewed by others
References
Airaksinen, M. M., Castrén, O., Friström, S., Saarikoski, S.: The effect of 6-OH-dopamine on the reproduction and NA and 5 HT contents of some tissues in mice. Acta pharmacol. (Kbh.) 31, suppl. 1, 18 (1972)
Ayitey-Smith, E., Varma, D. R.: An assessment of the role of the sympathetic nervous system in experimental hypertension using normal and immunosympathectomized rats. Brit. J. Pharmacol. 40, 175–185 (1970)
Berkowitz, B. A., Spector, S., Tarver, J. H.: Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine as immunosympathectomy. Brit. J. Pharmacol. 44, 10–16 (1972)
Chalmers, J. P., Reid, J. L.: The effects of intracisternal 6-hydroxydopamine on the development of neurogenic hypertension in the rabbit. J. Physiol. (Lond.) 219, 20–21 (1971)
Clark, D. W. J.: Effects of immunosympathectomy on development of high blood pressure in genetically hypertensive rats. Circulat. Res. 28, 330–336 (1971)
Clark, D. W. J., Laverty, R., Phelan, E. L.: Long-lasting peripheral and central effects of 6-hydroxydopamine in rats. Brit. J. Pharmacol. 44, 233–243 (1972)
Finch, L., Haeusler, G., Kuhn, H., Thoenen, H.: Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine. Brit. J. Pharmacol. 48, 59–72 (1973a)
Finch, L., Haeusler, G., Thoenen, H.: A comparison of the effects of chemical sympathectomy by 6-hydroxydopamine in newborn and adult rats. Brit. J. Pharmacol. 47, 249–260 (1973b)
Finch, L., Leach, G. D. H.: The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat. Brit. J. Pharmacol. 39, 317–324 (1970a)
Finch, L., Leach, G. D. H.: A comparison of the effects of 6-hydroxydopamine, immunosympathectomy and reserpine on the cardiovascular reactivity in the rat. J. Pharm. Pharmacol. 22, 354–360 (1970b)
Finch, L., Leach, G. D. H.: Does the adrenal medulla contribute to the maintenance of experimental hypertension? Europ. J. Pharmacol. 11, 388–391 (1970c)
Folkow, B., Hallbäck, M., Lundgren, Y., Weiss, L.: Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta physiol. scand. 80, 93–106 (1970)
Friedman, M., Freed, S. G.: Microphonic manometer for indirect determination of systolie blood pressure in the rat. Proc. Soc. exp. Biol. (N.Y.) 70, 670–673 (1949)
Haeusler, G.: Early pre- and postjunctional effects of 6-hydroxydopamine. J. Pharmacol. exp. Ther. 178, 49–62 (1971)
Haeusler, G., Finch, L., Thoenen, H.: Central adrenergic neurones and the initiation and development of experimental hypertension. Experientia (Basel) 28, 1200–1203 (1972a)
Haeusler, G., Gerold, M., Thoenen, H.: Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 211–228 (1972b)
Haeusler, G., Haefely, W., Thoenen, H.: Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol. exp. Ther. 170, 50–61 (1969)
Jaim-Etcheverry, G., Zieher, L. M.: Permanent depletion of peripheral norepinephrine in rats treated at birth with 6-hydroxydopamine. Europ. J. Pharmacol. 13, 272–276 (1971)
Laverty, R., Sharman, D. F., Vogt, M.: Action of 6-hydroxydopamine on storage and release of noradrenaline. Brit. J. Pharmacol. 24, 549–560 (1965)
Lundberg, D.: Studies on 6-hydroxydopamine in conscious rats. 6-Hydroxydopamine and Catecholamine Neurons. Communications and Discussion of a Symposium on 6-Hydroxydopamine. Buergenstock, Switz., Oct. 21–23, 1970, Malmfors, Torbjoern and H. Thoenen, Eds., pp. 225–237. North-Holland and Elsevier 1971
Nakamura, K., Gerold, M., Thoenen, H.: Experimental hypertension of the rat: reciprocal changes of norepinephrine turnover in heart and brain-stem. Naunyn-Schmiedebergs Arch. Pharmak. 268, 125–139 (1971a)
Nakamura, K., Gerold, M., Thoenen, H.: Genetically hypertensive rats: relationship between the development of hypertension and the changes in norepinephrine turnover of peripheral and central adrenergic neurons. Naunyn-Schmiedebergs Arch. Pharmak. 271, 157–169 (1971b)
Neuvonen, P. J., Hackman, C. R., Vapaatalo, H. I.: Effect of 6-hydroxydopamine on spontaneously hypertensive rats. Fifth Int. Congress on Pharmacology, San Francisco, July 23–28, 1972, p. 167. Abstracts of Volunteer Papers (1972)
Okamoto, K., Aoki, K.: Development of a strain of spontaneously hypertensive rats. Jap. Circulat. J. 27, 282–293 (1963)
Porter, C. C., Torato, J. A., Stone, C. A.: Effect of 6-OH-DA and some other compounds on the concentration of norepinephrine in the hearts of mice. J. Pharmacol. exp. Ther. 140, 308–316 (1963)
Sen, S., Smeby, R. R., Bumpus, F. M.: Renin in rats with spontaneous hypertension. Circulat. Res. 31, 876–880 (1972)
Smookler, H. H., Clarke, D. E., Erter, R. J.: Effects of 6-hydroxydopamine (6-HD) on the hypertension induced by environmental stress. Pharmacologist 13, 192 (1971)
Stock, K., Westermann, E.: Über die Bedeutung des Noradrenalingehaltes im Fettgewebe für die Mobilisierung unveresterter Fettsäuren. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 251, 465–487 (1965)
Thoenen, H., Tranzer, J. P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 261, 271–288 (1968)
Trendelenburg, U., Wagner, K.: Effect of 6-hydroxydopamine on the cat's nictitating membrane. Degeneration contraction and sensitivity to (−)-noradrenaline. 6-Hydroxydopamine and Catecholamine Neurons. Communication and Discussions of a Symposium on 6-Hydroxydopamine. Buergenstock, Switz., Oct. 21–23, 1970, Malmfors, Torbjoern and H. Thoenen, Eds., pp. 215–223. North-Holland and Elsevier 1971
Vapaatalo, H. I., Lahovaara, S., Hackman, R.: Studies with renal hypertensive rats. Ann. Med. exp. Fenn. 48, 28–32 (1970)
Wagner, K., Trendelenburg, U.: Development of degeneration contraction and supersensitivity in the cat's nictitating membrane after 6-hydroxydopamine. Naunyn-Schmiedebergs Arch. Pharmak. 270, 215–236 (1971)
Yamori, Y., Yamabe, H., De Jong, W., Lovenberg, W., Sjœrdsma, A.: Effect of tissue norepinephrine depletion by 6-hydroxydopamine on blood pressure in spontaneously hypertensive rats. Europ. J. Pharmacol. 17, 135–140 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vapaatalo, H., Hackman, R., Anttila, P. et al. Effects of 6-hydroxydopamine on spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 1–13 (1974). https://doi.org/10.1007/BF00499968
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499968